You are here: Home » News-CM » Companies » Results
Business Standard

Natco Pharma consolidated net profit declines 35.19% in the September 2019 quarter

Capital Market 

Sales decline 10.63% to Rs 485.70 crore

Net profit of Natco Pharma declined 35.19% to Rs 117.70 crore in the quarter ended September 2019 as against Rs 181.60 crore during the previous quarter ended September 2018. Sales declined 10.63% to Rs 485.70 crore in the quarter ended September 2019 as against Rs 543.50 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales485.70543.50 -11 OPM %27.6540.57 -PBDT161.30255.50 -37 PBT139.40235.30 -41 NP117.70181.60 -35

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, November 12 2019. 19:59 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU